Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-004197

Chief Technology Officer sold 14,545 shares at $8.22 ($119,534)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tyagarajan Seshu Chief Technology Officer 2025-01-08 Sale −14,545 $8.22 $119,534 111,112 D
Open-market sales · 14,545 sh · avg $8.22 · $119,534
Loading xslF345X05/ownership.xml…